Stanford Medicine X-Health Care and Emerging Technologies
Stanford Medicine X-Health Care and Emerging Technologies
批准号:
8431532
负责人:
LAWRENCE F CHU
金额:
$9.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2015-06-30
中文摘要
描述(由申请人提供):斯坦福大学医学X是一个致力于创新和新兴技术的应用,以改善医学和医疗保健的会议。我们会议的使命的核心创新的一个中心方面是重新设计慢性病患者的整个研究和护理系统。我们目前的系统可能代表了一个倒置的金字塔,知识和创新预计将从严格的等级制度的顶部涌现出来,具有高度专业化的学者和从业者
从上到下,并最终渗透到病人身上,我们的假设是,知识来自真实的专家:病人和他们的照顾者是有意义的。因此,我们相信,可以有一种新的方法来学术会议,将患者置于讨论的中心,并将所有医疗保健利益相关者-患者,医疗保健专业人员,技术人员和研究人员-团结在一起,以帮助解决以患者为中心的医疗保健问题。没有其他学术会议专门从以患者为中心的角度探索医疗保健和新兴技术的交叉点。该提案寻求通过AHRQ R13赠款机制提供资金,以支持2012年、2013年和2014年的会议。本提案中概述的会议的唯一PI是Larry Chu,医学博士,理学硕士,斯坦福大学麻醉信息学和媒体(AIM)实验室负责人,麻醉学副教授,以及斯坦福大学成功举办的医学2.0峰会和第四届世界大会的组织主席。斯坦福大学医学X将于每年9月在斯坦福大学校园的李嘉诚学习中心召开为期三天的会议。医学X的目标是:1。从以患者为中心的角度,促进了解创新技术如何有潜力改善患者护理并减轻疾病负担,包括使患者能够参与自己护理的工具。2.提供一个论坛,集中在团结利益相关者在卫生保健的机会,网络和合作的创新,跨学科的研究和/或技术解决方案。3.提供与新兴技术及其在临床医学中的应用相关的主要领域的教育。4.将患者的声音和以患者为中心的设计融入新兴技术的使用中,以改善医疗保健。5.确定对患者最有意义的可测量结果,并使研究人员更接近了解如何将以患者为中心的设计和结果纳入他们的研究。会议将是新兴技术和医学领域研究人员展示和发表他们的工作并与医疗保健提供者,患者,技术人员和学者等不同受众建立联系的主要场所之一。会议论文集将在官方开放获取会议期刊上发表:Journal of Visualized Experiments(JoVE)和Public Library of Science(PLoS ONE)。Medicine X在斯坦福大学医学院的位置使与会者能够接触到广泛的专家和硅谷无与伦比的技术专家和健康初创企业。
公共卫生相关性:斯坦福大学医学X会议将从以患者为中心的角度讨论新兴技术及其对医学和医疗保健未来的影响。没有其他会议专门从以患者为中心的角度探索医疗保健和新兴技术的交叉点。Medicine X专注于将医疗保健利益相关者聚集在一起,在研究人员,创新领导者和患者之间共享一个舞台。
英文摘要
DESCRIPTION (provided by applicant): Stanford Medicine X is a conference dedicated to innovation and the application of emerging technology to improve medicine and health care. One central aspect of innovation at the core of the mission of our conference is to re-engineer the entire system of research and care of patients with chronic disease. Where our current system might represent an upside-down pyramid where knowledge and innovation is expected to spring up from the top of a rigid hierarchy, with highly specialized academics and practitioners
at the top, and eventually trickle down to patients, our hypothesis is that it makes sense for knowledge to derive from the real experts: patients and their caregivers. Therefore, we believe that there can be a new approach to an academic conference that places the patient at the center of discussion and that will unite all healthcare stakeholders- patients, healthcare professionals, technologists, and researchers-together to help solve health care issues from a patient centered perspective. There is no other academic conference dedicated to exploring the intersection of healthcare and emerging technologies specifically from a patient-centered perspective. This proposal seeks funding through the AHRQ R13 grant mechanism to support the conference meetings in 2012, 2013, and 2014. The sole PI for the conference outlined in this proposal is Larry Chu, MD, MS, head of the Anesthesia Informatics and Media (AIM) Lab at Stanford, Associate Professor of Anesthesia, and Organizing Chair for the successful Medicine 2.0 Summit and 4th World Congress at Stanford. Stanford Medicine X will convene for three days annually in September at the Li Ka Shing Center for Learning on the Stanford campus. The objectives of the Medicine X are: 1. To advance understanding of how innovative technologies have the potential to improve patient care and ease the burden of disease from a patient-centered perspective, including tools to empower patients to be involved in their own care. 2. To provide a forum concentrated on uniting stakeholders in health care for opportunities to network and collaborate in innovative, interdisciplinary research and/or technology solutions. 3. To provide education in major areas relevant to emerging technology and their application to clinical medicine. 4. To integrate the patient voice and patient-centered design into the use of emerging technologies to improve health care. 5. To identify those measureable outcomes that are most meaningful to patients and to bring researchers closer to understanding how to incorporate patient-centered design and outcomes into their research. The meeting will be one of the major venues for researchers in the realm of emerging technology and medicine to present and publish their work and to network with a diverse audience of health care providers, patients, technologists, and academicians. Conference proceedings will be published in the official open access conference journals: Journal of Visualized Experiments (JoVE) and Public Library of Science (PLoS ONE). The location of Medicine X at the Stanford School of Medicine allows attendees the access to a breadth of experts and an unmatched number of technologists and health start-ups based in the Silicon Valley.
PUBLIC HEALTH RELEVANCE: The Stanford Medicine X conference will be a forum for discussion of emerging technologies and their impact on the future of medicine and health care, from a patient-centered perspective. There is no other meeting dedicated to exploring the intersection of healthcare and emerging technologies specifically from a patient- centered perspective. Medicine X is focused on bringing health care stakeholders together in an academic conference that shares a stage between researchers, leaders in innovation, and patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the Effects of Chronic Opioids Therapy in Humans
-
批准号:8636421
-
项目类别:
-
资助金额:$12.67万
-
财政年份:2013
-
负责人:LAWRENCE F CHU
-
依托单位:
Understanding the Effects of Chronic Opioids Therapy in Humans
-
批准号:8509170
-
项目类别:
-
资助金额:$12.67万
-
财政年份:2013
-
负责人:LAWRENCE F CHU
-
依托单位:
Stanford Medicine X-Health Care and Emerging Technologies
-
批准号:8530189
-
项目类别:
-
资助金额:$9.86万
-
财政年份:2012
-
负责人:LAWRENCE F CHU
-
依托单位:
Stanford Medicine X-Health Care and Emerging Technologies
-
批准号:8691496
-
项目类别:
-
资助金额:$9.85万
-
财政年份:2012
-
负责人:LAWRENCE F CHU
-
依托单位:
5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Phy
-
批准号:8240984
-
项目类别:
-
资助金额:$38.09万
-
财政年份:2011
-
负责人:LAWRENCE F CHU
-
依托单位:
5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Phy
-
批准号:8451522
-
项目类别:
-
资助金额:$37.11万
-
财政年份:2011
-
负责人:LAWRENCE F CHU
-
依托单位:
5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Phy
-
批准号:8041122
-
项目类别:
-
资助金额:$37.23万
-
财政年份:2011
-
负责人:LAWRENCE F CHU
-
依托单位:
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients
-
批准号:7118009
-
项目类别:
-
资助金额:$13.06万
-
财政年份:2004
-
负责人:LAWRENCE F CHU
-
依托单位:
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients
-
批准号:6807970
-
项目类别:
-
资助金额:$13.06万
-
财政年份:2004
-
负责人:LAWRENCE F CHU
-
依托单位:
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients
-
批准号:6918649
-
项目类别:
-
资助金额:$13.06万
-
财政年份:2004
-
负责人:LAWRENCE F CHU
-
依托单位:
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients
-
批准号:7476321
-
项目类别:
-
资助金额:$13.06万
-
财政年份:2004
-
负责人:LAWRENCE F CHU
-
依托单位:
国内基金
海外基金
Chinese Journal of Integrative Medicine
-
批准号:81224004
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2012
-
负责人:徐浩
-
依托单位: